05.12.2019 • NewsDede WillamsLanxess

Lanxess Signs “sustainable” Revolving Credit Facility

Lanxess Signs “sustainable” Revolving Credit Facility (c) Lanxess
Lanxess Signs “sustainable” Revolving Credit Facility (c) Lanxess

In a move setting it apart from most of its European peers, German specialty chemical producer Lanxess has agreed a new €1 billion syndicated credit facility carrying interest conditions linked to the successful reduction of its greenhouse gas emissions (Scope 1) and the increase in the proportion of women on the top three management levels.

The new facility with an initial term of five years as well as two options for one-year extensions replaces the syndicated loan of €1.25 billion expiring in May 2023.

With the new financial instrument, CFO Michael Pontzen said Lanxess is using the good capital market environment and its solid investment grade rating to secure its long-term financing on attractive terms while also underlining its commitment to achieving ambitious climate targets

Pontzen said Lanxess developed the “innovative financing concept” together with 12 banking partners as it is convinced that sustainable criteria are also becoming increasingly important for the capital markets.

Last month, the company announced that it will go climate neutral and eliminate its greenhouse gas emissions of currently around 3.2 million t/y of CO2 by 2040. This is ten years ahead of the German chemical industry’s target.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.